Winton Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-52,063
| Closed | -$5.8M | – | 700 |
|
|
2024
Q3 | $5.8M | Buy |
+52,063
| New | +$5.8M | 0.41% | 61 |
|
|
2023
Q1 | – | Sell |
-9,714
| Closed | -$1.55M | – | 1016 |
|
|
2022
Q4 | $1.55M | Buy |
+9,714
| New | +$1.55M | 0.1% | 279 |
|
|
2021
Q2 | – | Sell |
-6,752
| Closed | -$1.11M | – | 1466 |
|
|
2021
Q1 | $1.11M | Sell |
6,752
-796
| -11% | -$131K | 0.06% | 400 |
|
|
2020
Q4 | $1.25M | Sell |
7,548
-13,208
| -64% | -$2.18M | 0.09% | 292 |
|
|
2020
Q3 | $2.96M | Sell |
20,756
-37,812
| -65% | -$5.39M | 0.1% | 335 |
|
|
2020
Q2 | $6.46M | Sell |
58,568
-11,126
| -16% | -$1.23M | 0.17% | 133 |
|
|
2020
Q1 | $6.95M | Buy |
69,694
+13,387
| +24% | +$1.34M | 0.18% | 144 |
|
|
2019
Q4 | $8.41M | Buy |
56,307
+24,655
| +78% | +$3.68M | 0.12% | 295 |
|
|
2019
Q3 | $4.06M | Buy |
31,652
+26,710
| +540% | +$3.42M | 0.05% | 372 |
|
|
2019
Q2 | $705K | Buy |
4,942
+3,392
| +219% | +$484K | 0.01% | 531 |
|
|
2019
Q1 | $222K | Buy |
+1,550
| New | +$222K | ﹤0.01% | 920 |
|
|
2018
Q2 | – | Sell |
-1,736
| Closed | -$262K | – | 1093 |
|
|
2018
Q1 | $262K | Sell |
1,736
-334
| -16% | -$50.4K | 0.01% | 1029 |
|
|
2017
Q4 | $279K | Sell |
2,070
-1,675
| -45% | -$226K | 0.01% | 621 |
|
|
2017
Q3 | $548K | Buy |
3,745
+961
| +35% | +$141K | 0.02% | 530 |
|
|
2017
Q2 | $433K | Buy |
+2,784
| New | +$433K | 0.01% | 525 |
|